The Effect Of Cognitive Training On Sportıve Performance

August 9, 2021 updated by: Muhammet Ozalp, Nevsehir Haci Bektas Veli University

The Effect Of Cognıtıve-Based Neuromuscular Exercıses On Cognıtıve Functıons And Sportıve Performance In Football Players

The aim of this study is to examine the changes in cognitive performance, coordination, anticipation time, proprioception and pass quality of cognitive-based neuromuscular exercises.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The investigators think that with cognitive-based neuromuscular exercises to be applied to football players, concentration, reflexes, balance, coordination, anticipation time, proprioception and pass quality can be improved. Within the scope of the investigators' study,the investigators think that the positive effects of cognitive-based neuromuscular exercises on executive functions can positively affect athlete performance by contributing to rapid thinking, planning and implementation. In this way, footballers will be able to reach high performances on the field and will become more qualified athletes. In addition, it is predicted that the incidence of injuries in athletes will be minimized by improving the parameters such as anticipation time, balance, coordination, reaction time, and proprioception. If the effectiveness of the exercises is proven, it is aimed to contribute to the literature with objective and evidence-based results in order to include cognitive-based exercises in training programs, which are often overlooked in football training programs.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
24

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Kozakli
      • Nevşehir, Kozakli, Turkey, 50600
        • Kozaklİ Sport Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

16 years to 19 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • being healthy
  • 16-19 years old football players
  • footballers who train at least 3 days a week
  • agree to participate in the study

Exclusion Criteria:

  • who have had an injury in the last 6 months that could affect balance and performance
  • orthopedic, neurological or congenital problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Cognitive training
Cognitive-based neuromuscular exercises will be applied to the experimental group for a total of 8 weeks.
Other: Exercise
Cognıtıve-based neuromuscular exercıses will be applied.
Other: Classic Training
Classic match preparation training
Other: Control
The control group will only do the classic training.
Other: Classic Training
Classic match preparation training

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Cognitive performance
Time Frame: Change from baseline score at the end of 8 week
Lumosity is a cognitive training platform developed by containing the results of more than 600 million cognitive training tests from more than 35 million people, which contains the largest data set of human cognitive performance available, either web-based or accessible from a mobile phone application. One test selected for each parameter will be applied and evaluated from the tests that include 6 parameters, namely speed, memory, attention, cognitive flexibility, problem solving and mathematics, in cognitive functions through this program on the computer. Each test will be applied to the participants for the first 2 times to practice, and for the next 3 times to be used as a test score. Higher scores mean a better outcome.
Change from baseline score at the end of 8 week

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Reaction test
Time Frame: change from baseline time at the end of 8 week
Participants' visual reaction time will be measured in the study. The same working environment will be provided for all participants. During the test, Participants' eyes are focused on the screen and head is 40 cm from the screen. will be kept behind. In the choice reaction time test, there is more than one stimulus and each stimulus requires a different response. Four squares will appear on the computer screen and a different letter will be determined on the keyboard for each square. Whichever of the four squares is lit, the corresponding letter of that square will be asked to be pressed from the keyboard. Participants' reaction times to the stimulus will be recorded by the computer and their Choice Reaction Time averages will be determined.
change from baseline time at the end of 8 week
Coordination test
Time Frame: change from baseline score at the end of 8 week
The test allows evaluating the coordination of different parts of the body. The researcher throws the ball at a distance of 5 m to the player who is trying to play the ball in turn; The player is asked to play with the chest-foot-head, head-left foot-right foot, foot-chest-head in turn. The researcher calculates the sum of three trials. Unit of measure is 1 point per successful trial
change from baseline score at the end of 8 week
Anticipation time
Time Frame: change from baseline time at the end of 8 week
The time of anticipation will be calculated by means of computer software by measuring the time during which 10 bubbles seen on the computer monitor descend from top to bottom. The bubbles will first go down in red color, and when it comes to the last balloon, the color will turn green. After 5 retries, 20 repetitions will be made. As soon as the target bubble turns green, it will be asked to press the space key on the computer's keyboard, and the mean duration of the anticipation time error value will be calculated.
change from baseline time at the end of 8 week
Evaluation of Proprioceptive Force Sense
Time Frame: change from baseline score at the end of 8 week
A pressurized biofeedback device will be used to evaluate the proprioceptive force sensation in both knees. At the beginning of the test, the air-filled pressure bag of the device will be placed under the knee joint and the air pressure will be set to 20 mmHg. Individuals will be asked to perform the maximum voluntary isometric contraction of the M. Quadriceps femoris and 50% of this maximum value will be used in the assessment of proprioceptive force sense. Then, individuals will be asked to contact the M. Quadriceps femoris isometrically until participants reach the calculated proprioceptive force-sensing pressure value by following the device gauge. Single and dual tasks will be required from these processes. The process will be repeated three times and its average will be considered as the test result. High deviation scores indicate a feeling of weak knee joint proprioceptive force, while low deflection scores indicate a good sense of knee joint proprioceptive force.
change from baseline score at the end of 8 week
Loughborough Soccer Passing Test
Time Frame: change from baseline score at the end of 8 week
LSPT was developed to assess the multifaceted aspect of soccer skill including passing.
change from baseline score at the end of 8 week
Turkey Football Federation Club Injury Card:
Time Frame: through study completion, an average of 6 months
It consists of information including date of injury, time to return to active sports, injury site, injury type, injury mechanism, diagnostic methods and other details
through study completion, an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Nevsehir Haci Bektas Veli University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Muhammet Ozalp, Msc, Nevsehir Haci Bektas Veli University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
March 15, 2021

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 15, 2021

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 20, 2021

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 3, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 5, 2021

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 8, 2021

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 10, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 9, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • muhammetlifekinetik

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings